Trial NCT01891357

View at ClinicalTrials.gov 
Org. Study IDs: WSG-AM07 (Neo-PREDICT-HER2)
Secondary IDs: 2012-003679-21

Last trial update was posted on 2019-09-17

MeSH Interventions

Lapatinib Paclitaxel Trastuzumab

MeSH Conditions

Carcinoma, Ductal Carcinoma, Ductal, Breast

Other Conditions


Stopping Reasons

Early termination due to significant lack of relevant patient data for evaluation of objectives.

Limitations And Caveats

Only a limited number of core biopsies was available evaluation of dynamic biological changes. Very slow patient recruitment. Negative study results from ALTTO study did no longer justify further conduct.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID